Lensar received FDA 510(k) clearance for its next-generation Ally adaptive cataract treatment system, according to a press release.
Ally is the first FDA-cleared platform that allows cataract surgeons to complete femtosecond-laser-assisted cataract surgery (FLACS) in a single environment, the release said. The system uses adaptive intelligence to optimize fragmentation patterns and energy settings as well as to automatically determine cataract density.
“Our mission has been to develop a platform where surgeons can seamlessly perform the entire FLACS procedure in a single setting, improve